Patent directory · USPTO A61K / A61P
Patents matching “combination”
418 pharma patents match "combination" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 418 pharmaceutical patents matching "combination" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12090183
Methods of treating solid or lymphatic tumors by combination therapy
granted -
US 12090145
Combination therapy for treating or preventing depression or other mood diseases
granted -
US 12091460
Use of bispecific antigen-binding molecules that bind MUC16 and CD3 in combination with 4-1BB co-stimulation
granted -
US 12084516
Anti-C5 antibody combinations and uses thereof
granted -
US 12076324
Cancer treatments using combinations of CDK and ERK inhibitors
granted -
US 12076409
Polymer-drug conjugates for combination anticancer therapy
granted -
US 12077785
Chimeric antigen receptor polypeptides in combination with trans metabolism molecules modulating Krebs cycle and therapeutic uses thereof
granted -
US 12070500
Use of semaphorin-4D antibodies in combination with an immune modulating therapy to inhibit tumor growth and metastasis
granted -
US 12054557
Combination of anti-PD-1 antibodies and bispecific anti-CD20/anti-CD3 antibodies to treat cancer
granted -
US 12016860
Combination therapies with Cbl-b inhibitor compounds
granted -
US 12000829
Selection of patients for combination therapy
granted -
US 11980633
Method for treating cancer using a combination of DNA-damaging agents and DNA-PK inhibitors
granted -
US 11981921
TIL expansion processes using specific cytokine combinations and/or AKTi treatment
granted -
US 11974989
Therapeutic uses of glucokinase activators in combination with insulin or insulin analogs
granted -
US 11964016
Combination of IL-4/IL-13 pathway inhibitors and plasma cell ablation for treating allergy
granted -
US 11938124
Combination therapy for treatment of cancer
granted -
US 11931463
All-in-one fixed-dose combination for treating Helicobacter pylori infection
granted -
US 11890285
Combination therapies
granted -
US 11890289
Use of glucocorticoid receptor antagonists in combination with glucocorticoids to treat adrenal insufficiency
granted -
US 11883492
Combination treatment of chemoresistant cancers
granted -
US 11872200
GABA agonists in the treatment of disorders associated with metabolic syndrome and GABA combinations in treatment or prophylaxis of type I diabetes
granted -
US 11857531
Combination mast cell inhibition for treatment of BPH/LUTS
granted -
US 11833136
Therapeutic uses of glucokinase activators in combination with insulin or insulin analogs
granted -
US 11793819
Natural combination hormone replacement formulations and therapies
granted